These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22889821)

  • 1. Abdominal obesity and cardiovascular disease: is inflammation the missing link?
    Després JP
    Can J Cardiol; 2012; 28(6):642-52. PubMed ID: 22889821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
    Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
    Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
    Makkonen J; Westerbacka J; Kolak M; Sutinen J; Cornér A; Hamsten A; Fisher RM; Yki-Järvinen H
    Int J Obes (Lond); 2007 Oct; 31(10):1617-25. PubMed ID: 17452990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is visceral obesity the cause of the metabolic syndrome?
    Després JP
    Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PASSCLAIM--body weight regulation, insulin sensitivity and diabetes risk.
    Riccardi G; Aggett P; Brighenti F; Delzenne N; Frayn K; Nieuwenhuizen A; Pannemans D; Theis S; Tuijtelaars S; Vessby B
    Eur J Nutr; 2004 Jun; 43 Suppl 2():II7-II46. PubMed ID: 15221353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance training, visceral obesity and inflammatory response: a review of the evidence.
    Strasser B; Arvandi M; Siebert U
    Obes Rev; 2012 Jul; 13(7):578-91. PubMed ID: 22385646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.
    Zeyda M; Huber J; Prager G; Stulnig TM
    Obesity (Silver Spring); 2011 Apr; 19(4):743-8. PubMed ID: 20508627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat as a determinant of fibrinolysis and hemostasis.
    Mertens I; Van Gaal LF
    Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
    Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
    Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fat distribution and metabolism].
    Després JP; Lemieux I; Tchernof A; Couillard C; Pascot A; Lemieux S
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):209-14. PubMed ID: 11452212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
    Lastra G; Sowers JR
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.